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The BALB/c mouse model for human respiratory syncytial virus infection has contributed significantly to our understanding of the relative role
for CD4+ and CD8+ T cells to immune protection and pathogenic immune responses. To enable comparison of RSV-specific T cell responses in
different mouse strains and allow dissection of immune mechanisms by using transgenic and knockout mice that are mostly available on a C57BL/
6 background, we characterized the specificity, level and functional capabilities of CD8+ T cells during primary and secondary responses in lung
parenchyma, airways and spleens of C57BL/6 mice. During the primary response, epitopes were recognized originating from the matrix, fusion,
nucleo- and attachment proteins, whereas the secondary response focused predominantly on the matrix epitope. C57BL/6 mice are less permissive
for hRSV infection than BALB/c mice, yet we found CD8+ T cell responses in the lungs and bronchoalveolar lavage, comparable to the responses
described for BALB/c mice.
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Respiratory syncytial virus (RSV), a member of the family of
Paramyxoviridae, is the leading cause of viral lower respiratory
tract infection in early childhood. Although about 50 years have
elapsed since the virus was discovered, the essential parameters
that determine a severe disease course during primary infection
have not been unambiguously identified. Besides the burden
RSV infections pose on the population during primary disease,
which is usually attracted during the first year of life, the virus
also causes recurrent reinfections which are a main health
concern in elderly people and immune compromised individuals⁎ Corresponding author. Fax: +31 30 2505349.
E-mail address: g.vanbleek@umcutrecht.nl (G.M. van Bleek).
0042-6822/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2006.04.023(Falsey et al., 2005). Moreover, RSV lower respiratory tract
disease is followed by recurrent episodes of wheezing in a
considerable population of children (Bont et al., 2004). A safe
and effective vaccine is not available. A dramatic vaccine trial
was performed in the 1960s with formalin inactivated RSV (FI-
RSV). Vaccinees in this trial developed enhanced disease upon
exposure to the natural virus (Kim et al., 1969; Chin et al., 1969).
For the development of future vaccines that are highly protective
and safe, two essential points need to be addressed. First, how
can immune-mediated enhancement of disease be prevented?
And second, why is immunity incomplete after natural RSV
infection and how can this be improved by a vaccine?
Several aspects of the immune response against RSV
including the enhanced disease mechanism after FI-RSV
vaccination have been extensively studied in mouse models,
Table 1
Selection of peptides tested with Elispot assay and ICS
Sequence Protein Predicted restriction element
NAITNAKII M187–195 H-2D
b
VVLGNAAGL NP323–331 H-2D
b
ANHKFTGL NP57–64 H-2K
b
NPKDNDVEL NP383–391 H-2D
b
NGVINYSVL NP360–368 H-2D
b
YMLTNSELL F250–258 H-2D
b
IETVIEFQQKNNRLLEIT F216–234 H-2D
b
KTFSNGCDYV F433–442 H-2D
b
SNNPTCWAICKRIPNKKP G177–194 H-2D
b
SNNPTCWAICKR G177–188 H-2D
b
Sequences in bold are peptides that induced significant IFN-γ production by
CD8+ T cells after in vitro stimulation.
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hRSV infection (Prince et al., 1979; Waris et al., 1996). From
these studies, it was learned that CD4+ Th2 cells are a crucial
component of enhanced disease characterized by an eosinophilic
influx in the lungs that was also observed in FI-RSV vaccinated
children (Connors et al., 1992). The effect of this Th2 response
could be antagonized by an effective simultaneous CD8+ T cell
response, whereby high production of IFN-γ seemed crucial
(Srikiatkhachorn and Braciale, 1997; Hussell et al., 1997).
Another finding in BALB/c mice was that CD8+ T cells in
the lung tissue were partially functionally inactivated. This
conclusion was made from the observation that in the same
lung-derived cell sample, the number of CD8+ T cells specific
for a certain viral epitope as measured by H-2 tetramer staining
did not match up with the number of CD8+ Tcells that produced
IFN-γ upon an ex vivo stimulus with the same peptide (Chang
and Braciale, 2002). This discrepancy was not found in splenic
cell samples but only found in lung tissue when live virus was
present. The authors suggested that this functional impairment
of the CD8+ T cell response might have some relation with the
incomplete long-term memory against RSV (Chang and
Braciale, 2002). The mechanism by which CD8+ T cells
became inactivated is unclear. In in vitro responses with human
T cells, high surface expression of the F protein on accessory
cells was reported to impair the proliferative response of T cells
induced by a polyclonal stimulus (Schlender et al., 2002).
However, others have suggested the role of soluble factors as
the cause for impaired polyclonal T cell activation in the
presence of live RSV (Salkind et al., 1991; Preston et al., 1995;
de Graaff et al., 2005).
Genetic factors have been shown to affect susceptibility to
primary hRSV infection in mice as well as the nature of the
secondary immunological response to RSV infection after
vaccination (Hussell et al., 1998; Prince et al., 1979; Stark et al.,
2002). MHC genes and non-MHC genes both played a crucial
role in disease severity. Hence, the detailed study of T cell
responses in other mice strains besides BALB/c might further
our understanding of the mechanisms leading to protective
immunity or immune pathology. C57BL/6 mice have been
studied in various infection models in parallel to BALB/c mice.
From these studies, it has become clear that for certain
pathogens BALB/c mice are more prone to develop a Th2
skewed immune response whereas C57BL/6 mice elicit Th1
type responses (Sacks and Noben-Trauth, 2002; Guinazu et al.,
2004; Lenzo et al., 2003). This essential difference in pathogen-
specific immune responses as well as the fact that many
interesting transgenic and knockout mice are available on an H-
2b background determined our choice to characterize the CD8+
T cell response against RSV in the C57BL/6 mouse model.
Results
Identification of H-2b-restricted epitopes of RSV proteins by
Elispot
It has been reported that CD8+ T cells in the lungs of BALB/
c mice are functionally inactivated. To be able to judge whetherthis observation can be generalized to other mouse strains and to
study the mechanism of anti-viral T cell activation using
transgenic or KO mouse models, it was necessary to identify
CD8+ T cell epitopes in a different mouse strain. Because many
interesting genetically manipulated mice are available on an H-
2b background, we initiated an epitope search in C57BL/6 mice.
A panel of 18-mer peptides (12 amino-acid overlap) of the RSV-
F protein as well as a set of peptides derived from other RSV
proteins, predicted by algorithms for the MHC class I allele H-
2Db were synthesized (Table 1) (Rammensee et al., 1999;
Parker et al., 1994). We initially focused on H-2Db because it
appeared to be the main restriction element during RSV
infection in H-2b mice (Hussell et al., 1998). Splenocytes from
RSV-infected C57BL/6 mice were isolated 8 days after primary
infection and were stimulated with the synthetic peptides. The
peptides were tested for their capability to induce IFN-γ
production by T cells in an Elispot assay. The number of spot-
forming cells (SFC) per 106 cells was determined (Fig. 1). The
18-mer peptide set was initially tested as mixtures of 6
consecutive peptides, followed by tests with individual peptides
of positive pools. The most dominant response in C57BL/6 was
directed against the M187–195 sequence, derived from the matrix
protein. We further found substantial responses against two
sequences from the Fusion protein (F250–258 and F433–450), one
from the nucleoprotein (NP360–368) and a response against a
peptide representing amino acid residues 177–194 from the G
protein (G177–194).
Identified epitopes are recognized by CD8+ T cells
Because of the length of some of the peptides, the observed
responses in the Elispot assay could reflect CD4+ and/or CD8+
Tcell responses. Therefore, intracellular cytokine staining (ICS)
was performed to elucidate the role of CD4+ versus CD8+ T
cells. Peptides that gave a strong positive result with the Elispot
assay, as well as an extra peptide derived from the NP sequence
that was predicted to bind to H-2Kb and a shorter variant of the
sequence from the G protein, were used. Peptide F250–258
represented the nonamer contained in the two overlapping
peptides F241–258 and F247–264 that were identified by Elispot.
Lung lymphocytes from C57BL/6 mice isolated 8 days after
primary infection were stimulated for 6 h with the peptides. The
Fig. 1. Identification of immunodominant domains in RSV proteins. Mice were
intranasally infected with RSV, and 8 days later splenic lymphocytes were
incubated with 10 μg/ml synthetic peptides. T cells responding to synthetic
peptides in the cultures were enumerated with an IFN-γ Elispot assay. The
results from the positive pools, one negative pool and individual peptides are
shown. Error bars represent the standard error of the mean (SEM), results are
triplicate measurements of 1 mouse. An identical response pattern was observed
in three individual mice. The numbers given for the pools identify the stretch of
amino acid residues that is covered by the peptides in the pools.
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with ICS (Figs. 2A and 5C). All responses initially detected
with the Elispot assay appeared to be CD8+ T cell responses.
The dominant peptide M187–195 induced 13% of the lung CD8
+
T cells to produce IFN-γ. Peptides derived from the NP and F
proteins induced IFN-γ production, involving 2.3–8% of the
lung CD8+ T cells. In BALB/c mice, the lack of a G-specific
CD8+ T cell response after viral infection has been well
documented (Srikiatkhachorn and Braciale, 1997; Alwan et al.,
1994). Interestingly, we found that the response against the
peptides derived from the G protein were like the other
responses also CD8+ T cell mediated, with 8% of the CD8+ T
cells in lung responding to the G177–194 peptide. To confirm a
true CD8+ T cell response and determine the restriction element
for this G177–194-specific response, we performed ICS in the
presence of blocking antibodies specific for H-2Db and H-2Kb.
Furthermore, some samples were pre-incubated with an excess
of the Influenza NP366–374 or VSV NP52–59 peptides, well-
known binders for H-2Db and H-2Kb, respectively. The
incubation of CD8+ T cells with the anti-Db antibody or
competition with the influenza NP366–374 peptide reduced the
IFN-γ production by the G177–194 peptide to near background
levels, whereas pre-incubation with anti-Kb or the VSV NP52–59
had no effect on the G177–194-induced IFN-γ production (Fig.
2B). This result proved that the observed IFN-γ production
stimulated by G177–194 was a genuine CD8
+ T cell response.
The M187–195-specific primary CD8
+ T cell responses in the
lungs at day 8 post-infection
In BALB/c mice, it has been shown that the pulmonary RSV-
specific CD8+ T cell responses display a partially inactivated
phenotype (Chang and Braciale, 2002; Chang et al., 2001). To
determine whether a similar phenomenon happened in RSV-infected C57BL/6 mice, we compared M187–195 tetramer and
intracellular IFN-γ staining. Lung lymphocytes were stained
with an M187–195 tetramer and antibodies specific for the
activation markers CD11a and CD62L or NKG2a. These
antibodies were used to estimate the total number of recently
activated T cells present in the sample. In the lung tissue of
C57BL/6 mice undergoing a primary RSV infection, 46% of the
CD8+ T cells were activated as measured by up-regulation of
NKG2a expression (Fig. 2C; Table 2). This was similar to the
percentage of CD8+ T cells that had a CD11ahi and CD62Llow
phenotype (49%). In MOCK-infected mice, only 4.5% (average
3.1 ± 0.9%) of the CD8+ T cells in the lung had an activated
phenotype.
M187–195 tetramer staining revealed that 13% (12% average,
Table 3) of the CD8+ T cells in the lung stained positive (Fig.
2D). The background staining was only 0.27% in a MOCK-
infected mouse and 0.29% in a mouse going through a primary
influenza infection confirming the specificity of the tetramer. In
influenza-infected control mice, CD8+ T cells stained positive
(11%) with an influenza NP366–374 tetramer, which showed that
these mice had been properly infected. The M187–195-specific
response involved 28% of the CD11ahi/CD62Llow population of
CD8+ T cells in the lung tissue. Fig. 2E shows that virtually all
tetramer-positive cells indeed had the activated phenotype
(CD11ahi, CD62Llow, NKG2Apos). Thus, our data clearly
showed that the number of tetramer-positive cells was similar
to the number of cells that produced IFN-γ after in vitro
stimulation with the peptide (Table 3). Hence, in the C57BL/6
mouse strain, at day 8 after primary infection, we did not
observe the discrepancy found by Chang and Braciale (2002)
between the number of tetramer-positive and the number of
functional cells.
Transition of CD8+ T cells from effector to memory cells in the
lungs
To evaluate the possible inactivation of M-specific CD8+ T
cells during the transition of effector phase to the early memory
phase, we removed lung lymphocytes from mice 21 days p.i.
and stimulated these cells with the same epitopes used at day
8 p.i. The total number of T cells recovered from the lungs at
day 21 was twofold lower than at day 8. The percentage of
CD8+ T cells that produced IFN-γ also declined. The M187–195
peptide still was the dominant epitope, with 5% of the CD8+ T
cells producing IFN-γ. The other peptides induced IFN-γ
production that hardly reached above background levels (Figs.
3A and 5C). To study the activation status of these cells at this
time point, we stained the cells with the activation markers and
the M187–195 tetramer. There was a decline in the percentage of
activated CD8+ T cells, with about 38% (33% average in the
group; Table 2) CD8+ T cells remaining CD11ahi, CD62Llow.
About 35% (28% average in the group; Table 2) of the CD8+ T
cells also remained NKG2apos (Fig. 3B). Of the lung
lymphocytes, 8.5% of the CD8+ T cells stained positive with
the M187–195 tetramer (Fig. 3C; Table 3). Thus, at this time point
we found a discrepancy between the cells able to produce IFN-γ
and the cells that stained positive with the tetramer indicating
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Table 2
C57BL/6 mice were intranasally infected with 2.5 × 106 p.f.u. RSVA2
Lung parenchyma Lung airways
% NKG2apos % CD11ahi/
CD62low
% NKG2apos % CD11ahi/
CD62low
Day 8 46.4 ± 2.1 49.0 ± 0.3 69.3 ± 2.6 81.2 ± 2.7
Day 21 28.4 ± 2.5a 32.9 ± 5.9a 81.7 ± 2.5a 20.4 ± 2.6a, b
Lymphocytes obtained from the lung parenchyma and lung airways (of 4 mice
per group from 2 independent experiments) at indicated time points after
infection were stained with anti-CD8, anti-NKG2a or anti-CD11a and anti-
CD62L in combination with the M187–195 tetramer. Numbers represent the
percentage of NKG2apos, CD11ahi/CD62Llow CD8+ T cells of total CD8+ T
cells ± standard error of the mean (SEM).
a Denotes values with a significant difference between day 8 and day 21 in
surface expression of the selected marker (P < 0.01).
b The percentage of CD8+ CD62Llow was comparable to the percentage of
NKG2apos CD8+ T cells.
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capacity to produce IFN-γ in C57BL/6 mice.
Functional inactivation of M187–195-specific CD8
+ T cells in
the lungs
The inability of the M187–195-specific CD8
+ T cells of the
lungs to produce IFN-γ at day 21 after infection was studied
in more detail. To confirm that the inactivation was tissue
specific and not caused by technical procedures, we compared
the M187–195-specific CD8
+ T cell response in the spleen and
lungs at days 8, 21 and 28. According to the report by Chang
and Braciale (2002), the effect of CD8+ T cell inactivation is
restricted to the lungs. The percentage of M187–195-specific
CD8+ T cells in the lung parenchyma at day 8 was
comparable with the percentage of CD8+ T cells producing
IFN-γ after peptide stimulation, 12.1% tetramer-positive
versus 12.5% IFN-γ producing CD8+ T cells (Table 3). This
was also observed for CD8+ T cells in the spleen at day 8,
where 1.4% stained positive with the M187–195 tetramer and
1.6% produced IFN-γ after peptide stimulation.
As already observed, there was a discrepancy between
M187–195 tetramer-specific CD8
+ Tcells and the number of these
cells capable of producing IFN-γ at day 21 from the lung
parenchyma. Only 59% of the M187–195-specific CD8
+ T cells
produced IFN-γ, in contrast to the spleen where all M187–195-
specific CD8+ Tcells produced IFN-γ at day 21 after stimulation
with the M187–195 peptide (Table 3). The difference between
M187–195 IFN-γ production and M187–195 tetramer staining of
CD8+ Tcells in the lung parenchyma increased even more at dayFig. 2. Pulmonary CD8+ Tcell activation at day 8 after primary RSV infection. Pulmon
γ production was measured by intracellular staining. (A) The percentages of INF-γ p
right quadrant. One representative FACS plot is shown. Average percentages of the to
peptide-specific responses at different time points after primary (days 8, 21 and 28
production after pre-incubation with blocking antibodies or peptide competition. (C) E
Numbers represent the percentage of live CD8+ T cells in each quadrant. Average per
lymphocytes 8 days p.i. were stained with M187–195 (RSV) or NP366–374 (Influenz
Pulmonary CD8+ T cells were stained with anti-NKG2a, anti-CD11a or anti-CD62L
CD8+ Tcells of total pulmonary CD8+ Tcells. The pictures shown are representative of
tetramer-positive cells and SEM of the total group can be found in Table 3.28 after primary infection. Only 41% of the M187–195-specific
CD8+ T cells in the lung parenchyma were functional, whereas
83% of these cells in the spleen were functional.
RSV-specific responses in bronchoalveolar lavage
In addition to the immune response in the lung parenchyma,
we also studied the RSV-specific response by the pulmonary
inflammatory cells in the lung airways 8 and 21 days after RSV
infection (Fig. 4). We eluted these cells by bronchoalveolar
lavage and examined the activation status of these cells. In the
BAL at day 8, about 75% (69% average in the whole group) of
the CD8+ T cells could be identified as activated with an
NKG2apos, CD11ahi and CD62Llow phenotype (Fig. 4A; Table
2). Of the CD8+ T cells in the BAL, 20% stained positive with
the M187–195 tetramer, with all the tetramer-positive cells being
NKG2apos, CD11ahi and CD62Llow (Fig. 4A; Table 3).
When we applied the same procedure at day 21 post-
infection, the majority (81% average in the group; Table 2) of
CD8+ T cells remained NKG2apos. The CD62L expression was
low on 86% of the cells. However, the expression of CD11a
declined, only 30% (20% average in the group; Table 2) of the
CD8+ T cells had the CD11ahi, CD62Llow phenotype (Fig. 4B).
Despite the low CD11ahi expression by CD8+ Tcells, more than
34% of CD8+ T cells stained positive with the M187–195
tetramer. These M187–195-specific CD8
+ T cells predominantly
had an NKG2apos, CD62Llow phenotype. Of the M187–195-
specific CD8+ T cells, only 16.5 ± 3% were CD11ahi. These
results suggested that there is an efflux of activated M187–195-
specific CD8+ T cells from the lung parenchyma into lung
airways, where the expression of CD11a is progressively lost.
When we looked at the functional responses in the BAL,
initially at day 8 after primary infection, the ratio IFN-γ versus
tetramer-positive cells was higher than in the lung parenchyma.
However, at day 28 the functional inactivation was also found in
the BAL (Table 3).
Secondary M187–195-specific CD8
+ T cell responses in the
lungs
The hierarchy of CD8+ T cell immune responses can change
after a secondary infection. To test if there was a difference in
hierarchy after a secondary RSV infection in the C57BL/6 RSV
model, we infected C57BL/6 mice with RSV and 4 weeks later
they were intranasally challenged with the same dose of RSV.
The lung parenchyma and splenic CD8+ T cells were analyzed
6 days after challenge for their capability to produce IFN-γ afterary lymphocytes were incubated with synthetic peptides (1 μM) for 6 h and IFN-
roducing CD8+ T cells responding to individual peptides are shown in the upper-
tal groups of mice tested and SEM are depicted in Fig. 5C, where the hierarchy of
) and secondary (day 6) RSV infections are summarized. (B) Relative IFN-γ
xpression of NKG2a, CD11a and CD62L on pulmonary CD8+ Tcells at day 8 p.i.
centages and SEM for the total group are summarized in Table 2. (D) Pulmonary
a) tetramer. Numbers represent the percentage of tetramer+ CD8+ T cells. (E)
in combination with the M187–195 tetramer. Numbers represent the percentage of
four mice per group and two/three individual experiments. The average values of
Table 3
C57BL/6 mice were intranasally infected with 2.5 × 106 p.f.u. RSVA2
Lung parenchyma Lung airways Spleen
% Tet+/CD8+ % IFN-γ+/CD8+ % IFN-γ+/Tet+ % Tet+/CD8+ % IFN-γ+/CD8+ % IFN-γ+/Tet+ % Tet+/CD8+ % IFN-γ+/CD8+ % IFN-γ+/Tet+
Day 8 12.1 ± 1.5 12.5 ± 0.8 103.2 ± 3.6a 20.2 ± 4.0 39.5 ± 4.0 195.5 ± 8.9a 1.4 ± 0.2 1.6 ± 0.1 114.3 ± 8.9
Day 21 8.5 ± 1.5 5.0 ± 0.4 58.9 ± 3.9b 30.0 ± 3.3 38.9 ± 5.4 128.2 ± 8.7b 0.5 ± 0.1 0.6 ± 0.1 128.9 ± 18, ns
Day 28 9.1 ± 1.3 3.5 ± 0.4 41.3 ± 7.2b 24.4 ± 2.6 13.6 ± 1.5 55.7 ± 2.5b 0.9 ± 0.1 0.7 ± 0.2 83.9 ± 11.6, ns
Lymphocytes obtained from the lung parenchyma, lung airways and spleen (of 4 mice per group from 2 independent experiments) at indicated time points after
infection, were stimulated with M187–195 peptide for intracellular cytokine staining or stained directly with anti-CD8 and M187–195 tetramer. The values represent the
percentages of CD8+ T cells staining positive for either IFN-γ or the M187–195 tetramer ± standard error of the mean (SEM). Percentages of IFN-γ producing cells
among M187–195 Tet
+ were calculated by dividing the percentage of IFN-γ+/CD8+ by the percentage of M187–195 Tet
+/CD8+ at each time point. ns, not significantly
different from day 8.
a Denotes significant difference between day 8 lung parenchyma and lung airways (P < 0.001).
b Denotes values that significantly differ from day 8 (P < 0.001).
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remained the dominant epitope, with >17% (14% average in
the group; Fig. 5C) of the CD8+ T cells producing IFN-γ afterFig. 3. Pulmonary CD8+ T cell activation at day 21 p.i. (A) Pulmonary lymphocytes
intracellular cytokine staining. The percentages of IFN-γ+ CD8+ T cells out of total li
of the total group are summarized in Fig. 5C. (B) Expression of NKG2a, CD11a an
percentage of live CD8+ T cells in each quadrant. Average data of the total group a
NKG2a, anti-CD11a or anti-CD62L in combination with the M187–195 tetramer. A
represent the percentage of CD8+ T cells in the quadrant. Pictures are representativestimulation (Fig. 5A). Furthermore, the results showed that the
NP360–368 epitope was the second dominant epitope with 4.2%
IFN-γ-positive CD8+ T cells. There was no clear hierarchywere incubated with synthetic peptides and IFN-γ production was measured by
ve CD8+ T cells are shown in the upper-right quadrant. Average values and SEM
d CD62L on pulmonary CD8+ T cells at day 21 p.i. The numbers represent the
re summarized in Table 2. (C) Pulmonary CD8+ T cells were stained with anti-
verage group values of tetramer-positive cells are given in Table 3. Numbers
for four individual mice per experiment and two different experiments.
Fig. 4. CD8+ Tcell activation in the BAL over time following RSV infection. Expression of activation markers on CD8+ Tcells on (A) day 8 p.i. and (B) day 21 p.i. The
numbers in the quadrants represent the percentage of cells out of total BAL CD8+ Tcell numbers. The pictures shown represent the data from pooled BAL samples of 4
individual mice. The average values and SEM of the fraction of cells expressing activation markers NKG2a and CD11a can be found in Table 2.
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hardly stimulated any IFN-γ production. Results obtained with
control mice undergoing a primary MOCK infection that were
challenged 4 weeks later with RSV had 4.3 ± 1.3% of the lung
CD8+ T cells producing IFN-γ after M187–195 stimulation on
day 6 p.i. (Fig. 5B). This showed that during a “primary”
infection on day 6, the response against the M187–195 epitope
was significantly lower compared with 14% IFN-γ production
after M187–195 stimulation during a recall response. Fig. 5C
summarizes the observed CD8+ T cell response (average
values of the groups) for the different epitopes at several time
points and clearly shows that the secondary response in all
the mice was less heterogeneous in the lung parenchyma than
the primary response. The substantial responses against the
G177–194, NP57–64 and F433–442 epitopes observed during the
primary response was not found during the secondary
response. In contrast, more CD8+ T cells responded to
NP360–368 during the secondary response than during the
primary response. The boost in the secondary response was not
observed in the spleen.Discussion
CD8+ cytotoxic T lymphocytes play a crucial role in the
clearance of RSV infections in humans and in mice. However,
most of the studies in the mouse model have been performed in
the BALB/c strain, leaving open the question whether important
phenomena, such as the functional inactivation of lung CD8+ T
cells (Chang and Braciale, 2002), are strain specific or will
also occur in mice with different genetic backgrounds. To
address such questions, we have identified a panel of H-2b-
restricted CD8+ T cell epitopes derived from the M, NP, F and
G proteins of RSV A2. The M187–195 epitope was recently
reported by Rutigliano et al. (2005). This group discovered
only the M187–195 epitope, probably because they used as a T
cell source, spleen cells derived from C57BL/6 mice after
secondary virus infection. In the present paper, we observed an
altered epitope hierarchy during primary and secondary RSV-
specific T cell responses, whereby the secondary response was
indeed dominated by CD8+ T cells responding to the M187–195
epitope. Such altered hierarchy in epitope recognition during
164 M.V. Lukens et al. / Virology 352 (2006) 157–168primary and secondary responses has also been described for
influenza epitopes, where it appeared to be the result of
differences in epitope expression by different antigen present-
ing cell types (Crowe et al., 2003). Most of the identified
epitopes contained an H-2Db binding motif, whereas one
peptide NP57–64 harbored an H-2K
b binding motif. The G177–194
peptide did not contain a clear binding motif for either H-2Db
or H-2Kb, although H-2Db was found to be the restriction
element by means of antibody blocking and peptide competi-
tion studies. However, attempts to identify the minimal G
epitope were unsuccessful. Contamination with one of the other
peptides could be excluded by mass spectrometry (ms) and
tandem mass spectrometric sequencing. We are currently
working on different approaches to solve the structure of the
naturally presented G peptide.
The fact that we found a G-derived peptide that was
recognized by CD8+ T cells was interesting because many
reports suggested that the G protein is poorly recognized by
CD8+ T cells (Bangham et al., 1986; Srikiatkhachorn and
Braciale, 1997; Nicholas et al., 1990). In BALB/c mice, the G-
specific CD8+ T cell response is clearly absent. This lack of an
H-2b-restricted G-specific CD8+ T cell response has been held
responsible for the enhanced CD4+ Th2 response causing lung
eosinophilia after vaccination employing the G protein as sole
RSV component (Alwan et al., 1994; Srikiatkhachorn and
Braciale, 1997). Interestingly, the same priming procedure did
not lead to the enhanced disease in C57BL/6 mice (Hussell et
al., 1998). The presence or absence of CD8+ T cell responsesdirected against the G protein in different mouse strains that are
relatively resistant to eosinophilic lung disease has not been
extensively studied. A possible explanation for the resistance of
C57BL/6 mice for enhanced disease after G priming could be
the presence of the CD8+ T cell epitope in the G protein. This
CD8 epitope might elicit a memory T cell response that could be
sufficient to regulate the CD4+ T cell response upon viral
challenge.
Eight days after primary intranasal infection with RSV, more
than 12% of the CD8+ T cells in the lungs recognized the
dominant M187–195 peptide. In several reports, it has been
shown that NKG2a is up-regulated by CD8+ T cells after
contact with antigen and remains expressed long after (Moser et
al., 2002). This marker was therefore used as a surrogate
activation marker for antiviral CD8+ T cells (Gold et al., 2004;
Claassen et al., 2005). We found that at day 8 p.i. about 45% of
the CD8+ T cells in the lungs expressed NKG2a. This number is
similar for the CD11ahi/CD62Llow population. Of the activated
pulmonary CD8+ T cells, 25% recognized the M187–195 epitope
as measured by tetramer staining. Indeed, all M187–195-specific
cells were CD11ahi/CD62Llow and NKG2apos. Furthermore, the
percentage of tetramer-positive cells matched with the percent-
age of IFN-γ-positive cells. This means that in contrast to CD8+
T cell responses in BALB/c mice all the specific CD8+ T cells in
the lungs of C57BL/6 mice were fully functional at day 8 after
infection (Chang and Braciale, 2002). If we would assume that
also for the other epitopes T cells were fully functional at day 8,
this would suggest that the epitopes we have characterized
Fig. 5. Epitope hierarchy during RSV-specific CD8+ T cell recall responses in the lung. Pulmonary tissue lymphocytes obtained 6 days after intranasal challenge
infection with 2.5 × 106 p.f.u. RSV were in vitro stimulated with synthetic peptides (1 μM) and IFN-γ production was measured using intracellular staining. (A)
Primary infection 2.5 × 106 p.f.u. RSV intranasally; (B) primary MOCK infection. The percentages of IFN-γ+ CD8+ T cells of total CD8+ T cells are shown in the
upper-right quadrant. Pictures represent one individual mouse out of 5. (C) Summary of the average fraction of responding CD8+ T cells against the panel of RSV
epitopes at different time points after primary and secondary RSV infection. Data from 5 mice of two independent experiments, error bars represent the SEM.
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as measured by the total number of NKG2apos, CD11ahigh and
CD62Llow CD8+ T cells.
The memory response against RSV is usually incomplete and
individuals can be re-infected within a short period with the
same strain (Hall et al., 1991). One possible explanation for the
inefficient induction of T cell memory might be the CD8+ T cell
inactivation that occurs in RSV-infected lungs that was observed
in BALB/c mice (Chang and Braciale, 2002). When we studied
the transition from effector to early memory phase at days 21 and
28 post-infection in C57BL/6 mice, we found that the decline in
IFN-γ producing CD8+ T cells was greater than the decline inactivated CD8+ T cells defined as NKG2apos, CD11ahi and
CD62Llow. Tetramer staining at these time points showed that
M187–195 CD8
+ Tcells were present, but they started to lose their
functional response, like it was described for CD8+ T cell
responses in the lungs of RSV-infected BALB/c mice. The effect
of functional inactivation on viral clearance is yet to be
determined. However, we showed that upon secondary infection
to RSV a robust recall response could be measured against the
matrix epitope. These matrix-specific T cells could potentially
contribute to viral clearance.
Functional inactivation has also been described for other
viruses from the Paramyxoviridae family (Gray et al., 2005;
166 M.V. Lukens et al. / Virology 352 (2006) 157–168Chang and Braciale, 2002; Claassen et al., 2005). The fact that
the decrease of function started later during primary RSV
infection in C57BL/6 mice might be explained by a lower
replication of RSV in the lungs of C57BL/6 mice compared
with BALB/c mice. Interestingly, Ostler et al. found a more
delayed decrease in the number of functional T cells in RSV-
infected BALB/c mice lungs than Chang et al. (2001), which
may be related to differences in levels of virus replication
reached in the experiments performed by both groups (Ostler
and Ehl, 2002; Chang and Braciale, 2002). Furthermore, our
observation that functional inactivation increases over time is in
agreement with findings for RSV, pneumonia virus of mice
(PVM) and simian virus 5 (SV5) infections in BALB/c mice
(Chang and Braciale, 2002; Gray et al., 2005; Claassen et al.,
2005).
In contrast to the lower numbers of epitope-specific cells
detected with the intracellular cytokine staining assay
compared to the direct tetramer staining in the lung
parenchyma, we found the opposite in the BAL, that is,
higher numbers of IFN-γ producing cells than tetramer-
positive cells (Table 3). A possible explanation for this
observation could be that in the BAL CD8+ T cells had been
recently exposed to antigen, which leads to initial T cell
receptor down-regulation followed by re-expression. As a
result, tetramer staining may be ineffective because the
distribution of the T cell receptors on the cell surface may be
diffused in the early phase of re-expression although the
functional responses triggered by antigenic peptides are
effective (Drake et al., 2005).
In conclusion, we have identified a panel of MHC class I
epitopes from the F, M, NP and G protein of RSV A2. The
responses against the dominant M187–195 are fully functional at
day 8 during a primary infection. However, at later time points,
part of the cells become functionally inactive when triggered via
the T cell receptor with cognate antigen. The number of
dysfunctional cells increased over time, which was in agreement
with observations made for other members of the Paramyx-
oviridae family. However, our data also suggest that the kinetics
of inactivation differs between C57BL/6 and BALB/c mice, and
it is tempting to speculate that this may be driven by different
viral loads.
Materials and methods
Mice
Pathogen-free 6- to 8-week-old female C57BL/6cjo were
purchased from Charles River Nederland (Maastricht, The
Netherlands). The mouse study protocols were approved by the
Animal Ethics Committee of the Medical Faculty of the Utrecht
University.
Viruses and infections
RSVA2 strain was grown in HEp-2 cells, purified by PEG
precipitation and stored in liquid nitrogen in 25% sucrose in
PBS. Mice were lightly anesthetized with ether and intranasallyinfected with 2.5 × 106 p.f.u. RSV in a volume of 50 μl or with 1
hemagglutination unit influenza A/NT/60/68 in 50 μl diluted in
PBS with 10% sucrose.
Peptides
The RSV proteome with the exception of the L protein was
screened for predicted epitopes for the H-2Db and the H-2Kb
alleles, using the algorithms for epitope prediction of the
SYFPEITHI (http://www.syfpeithi.de) (Rammensee et al.,
1999) and BIMAS Web sites (http://www.bimas.dcrt.nih.gov/
molbio/hla_bind/) (Parker et al., 1994). Only predicted
epitopes present in the top ten in both databases were
synthesized and screened (Table 1). All peptides were
synthesized by standard solid-phase Fmoc chemistry. In recent
work, we had prepared a set of overlapping 18 amino acid
long peptide amides that overlapped by 12 residues, spanning
the entire F protein (van Bleek et al., 2003).
Tissue sampling
Mice were sacrificed by i.p. injection of 300 μl
pentobarbital. Effector cells from the lung airways were
obtained by performing a bronchoalveolar lavage (BAL) with
5 × 1 ml of 0.15 M NaCl. Prior to removal, the lungs were
perfused with PBS containing 100 U/ml heparin. Lungs were
sliced to 1 × 1 mm pieces that were incubated for 30 min at
37 °C with collagenase (2.4 mg/ml; Roche Applied Science,
Basel, Switzerland) and DNAase (1 mg/ml; Roche Applied
Science, Basel, Switzerland). Single cell suspensions were
prepared from the pre-treated lungs and spleen by processing
the tissue trough cell strainers. Spleen cells were depleted of
erythrocytes by treatment with buffered ammonium chloride
solution.
Elispot assay
The IFN-γ Elispot assay was performed on splenocytes of
mice obtained 8 days after primary infection, using the mouse
IFN-γ Elispot pair (U-cytech, Utrecht, The Netherlands) and
Multiscreen-IP filter plates (Millipore, Billerica, MA) according
to the manufacturers instructions. Cells were stimulated in
200 μl IMDM (Gibco, Invitrogen) containing 10% FCS,
penicillin/streptomycin and 50 μM 2-mercapto-ethanol with
10 μg/ml peptide for 24 h at 37 °C, 5% CO2.
Intracellular cytokine staining (ICS)
For ICS analysis, single cell suspensions of BAL, lung and
spleen cells (106) were stimulated for 6 h at 37 °C, 5% CO2
with 1 μg/ml peptide in 200 μl IMDM (Gibco, Invitrogen)
containing 10% FCS, penicillin/streptomycin and 50 μM 2-
mercapto-ethanol. Brefeldin-A 10 μg/ml (Sigma, St. Louis,
MO) was added for the duration of the stimulation to
facilitate intracellular accumulation of cytokines. To deter-
mine the restriction element for the G177–194 peptides, we
incubated lung cells with blocking antibodies to H-2Db or H-
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b) or VSV
peptide NP52–59 (H-2K
b) for 30 min at 37 °C, 5% CO2,
before the G177–194 peptide from RSV was added. After 5 h
of stimulation with the G177–194 peptide, the cells were
washed with PBS containing 2% FCS, 2 mM EDTA and
0.02% NaN3 (FACS buffer) and surface stained for flow
cytometric analysis. Before intracellular staining, cells were
fixed and permeabilized with CytoFix/CytoPerm solution and
Perm/Wash buffer (BD Pharmingen, San Diego, CA) accord-
ing to instructions of the manufacturer.
Flow cytometric analysis of CD8+ T cells
MHC class I-peptide tetramers were produced as described
(Haanen et al., 1999). Freshly isolated BAL, lung or spleen
lymphocytes were stained in FACS buffer, using fluorochrome-
conjugated antibodies and M187–195 RSV- and NP366–374
Influenza-MHC class I tetramers. The antibodies, anti-CD8
(clone 53–6.7), anti-CD11a (2D7), anti-CD62L (clone MEL-
14) and anti-NKG2a (20D5) were used for cell surface staining.
For intracellular IFN-γ staining, we used the rat-anti-mouse
IFN-γ FITC (clone XMG 1.2). All antibodies were purchased
from BD Pharmingen (San Diego, CA). Stained samples were
acquired on a FACSCalibur flowcytometer (BD, San Diego,
CA). Data were analyzed using CellQuest software (BD, San
Diego, CA).
Statistical analysis
Data were analyzed for statistical significance using a
Students t test. Data are expressed as the mean ± standard
error of the mean (SEM). A P value <0.05 was taken as the
level of significance.
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